OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Publication Date
Release Date
2022
(1)
2015
(1)
2014
(1)
2012
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.
Not available
S-EPMC4094257
|
biostudies-literature
Cite
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.
Not available
S-EPMC4025728
|
biostudies-literature
Cite
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes.
Not available
S-EPMC4434471
|
biostudies-literature
Cite
Stroke genetics informs drug discovery and risk prediction across ancestries.
Not available
S-EPMC9524349
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets